Amidst rising concerns within the NHS, Nervecentre is embracing 2024 with optimism as it secures new contracts and expands its electronic patient record (EPR) offerings.
The company recently became the preferred EPR supplier for three NHS trusts and secured a contract with Ireland’s health service. Nervecentre’s CEO, Paul Volkaerts, expressed confidence in the company’s growth prospects, highlighting its focus on the UK health service.
With a strong emphasis on usability and tailored solutions for the NHS, Nervecentre aims to address the healthcare challenges across regions, fostering seamless patient data integration.
Expanding Impact and Overcoming Challenges
Nervecentre’s recent EPR wins are part of its strategy to create a region with seamless patient data and consolidate services across regions. However, the company acknowledges the challenges of digital transformation and the need for progressive implementation to minimize disruptions.
As the NHS prioritizes digitalization, Nervecentre’s tailored EPR solutions and focus on the UK health service position it as a viable option for trusts seeking reliable and efficient digital systems.
